These stocks offer pleasing income. The post Why I think these 2 ASX dividend shares are ideal for income investors appeared ...

Q1 2025 Management View CEO Henry Fernandez highlighted MSCI's financial performance with 10% organic revenue growth, 11% adjusted EBITDA growth, and a 14% increase in adjusted EPS. The company ...

S4 Capital’s business is smaller and less diverse than that of larger advertising holding companies, making it more susceptible to economic downturns and higher volatility in its operating and credit ...

RTX Corporation highlighted an 8% organic sales growth for Q1 2025, driven by strong performances across key segments. Commercial aftermarket sales rose by 21%, commercial OE sales increased by 3%, ...

While total sales growth decelerated for 3M's Safety & Industrial segment, they ticked up sequentially in organic growth.

Kotak Institutional Equities initiated coverage on Dr Agarwal's Health Care with an 'Add' rating and Rs 425 target, citing ...

We see a compelling investment case in Ducommun, a military and commercial aerospace supplier. Click here for our thesis on ...

Aryzta reported higher first-quarter revenue driven by growth in the Europe segment and said it was on track to meet its low to mid-single digit organic growth target for this year.

ARYZTA AG / Key word (s): Sales Result Solid start to 2025 - Organic growth in line with low to mid-single digit target 22-Apr-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art.

Xvivo Perfusion AB (XVIPF) reports strong financial performance with significant growth in thoracic sales and strategic ...

Omnicom, working toward finalising the acquisition of competitor IPG later this year, is developing plans for integrating its ...